CAC
BNTX icon

Cowen and Company’s BioNTech BNTX Stock Holding History

Cowen and Company’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,402
Closed -$998K – 52
2024
Q3 		$998K Buy
+8,402
New +$772K 0.03% 153
2022
Q1 		– Sell
-1,490
Closed -$384K – 616
2021
Q4 		$384K Buy
+1,490
New +$408K 0.03% 251
2020
Q2 		– Sell
-10,000
Closed -$584K – 404
2020
Q1 		$584K Buy
+10,000
New +$389K 0.13% 115

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Cowen and Company's BNTX Position: Q4 2024 in Review

Cowen and Company sold out of BioNTech (BNTX) in Q4 2024, closing a stake of 8,402 shares — an estimated $998K sold.

Cowen and Company first reported a position in BNTX in Q1 2020 and held it in 3 quarters. The position peaked at $998K in Q3 2024. 303 funds tracked by Wall St. Rank hold BNTX as of Q4 2024.

  • Cowen and Company reported no remaining BioNTech position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 8,402 BioNTech shares in Q4 2024, an estimated $998K.
  • Cowen and Company first reported a position in BioNTech in Q1 2020 and held it in 3 quarters.
  • Cowen and Company's BioNTech position peaked at $998K in Q3 2024.
  • 303 funds tracked by Wall St. Rank held BioNTech as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.